Focus on the essentials: New series of TEGO® defoamers for architectural coatings makes it possible!
The new TEGO® Foamex series 10 to 34 from Evonik enables customers to concentrate on the essentials: developing innovative architectural coatings.
Foam formation during production and application is a common problem with architectural coatings that takes up a great deal of time in the development of new innovations. Low-VOC, ecolabel-compliant, and efficient: The new defoamers reduce production times, define filling capacity more precisely, and improve the appearance and performance of architectural coatings with minimal investment.
Developers also need to find out about new raw materials and changes in the law. That means more work for the laboratories as the necessary know-how rarely comes in a package. This is now set to change because the new series of TEGO® Foamex 10 to 34 defoamers has been developed to meet all requirements pertinent to architectural coatings.
“In launching this new series of TEGO® defoamers, we are solving an annoying, time-consuming problem for our customers,” explains Daniel Brünink, director global marketing for decorative coatings. “In many cases, we therefore decide with the customer which defoamer is the best fit for their particular situation. However, it is also easy to choose a suitable defoamer by performing own tests.”
The new TEGO® Foamex defoamers do not have a negative impact on VOC or environmental labels. Thanks to the diversity of products offered, customers can rest assured that the right defoamer is available for all relevant formulations in the field of architectural coatings.
With its TEGO® Foamex products, Evonik has 30 years of experience in foam control in many segments of the paint industry.
The new portfolio comprises ten defoamers with different performance profiles and cost structures.
More information is available at www.tego.de.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.
Evonik Industries has been producing specialty chemical products in the Greater China region (Mainland China, Hong Kong and Taiwan) since the late 1970’s; with wide-ranging trading relations already in place prior to this in the region. Evonik regards Greater China as one of the driving forces of the global economy and we consequently endeavor to grow our business in the region. The company now has around 3,000 employees in the Greater China region, the regional sales reached over €1.3 billion in 2015.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.